Desvenlafaxine 10135-0821-10
- Manufacturer
- Marlex Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 1, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA204805
Need to source Desvenlafaxine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Desvenlafaxine Succinate | 50 mg/1 |
Drug Class
Cytochrome P450 2D6 Inhibitors [MoA]Norepinephrine Uptake Inhibitors [MoA]Serotonin Uptake Inhibitors [MoA]
Selected Package
10135-0821-10Selected1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-821-10)
Other packages for this product(3)
14 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-821-14)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-821-30)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-821-90)